首页> 外文期刊>Internal medicine journal >Misconduct in medical research: whose responsibility?
【24h】

Misconduct in medical research: whose responsibility?

机译:医学研究中的不当行为:谁负责?

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Examples of many types of misconduct in medical research continue to be reported. The true incidence is unknown because there is strong evidence of under-reporting as well as suggestions of increased detection. Risks to research participants may also be increasing, with contributing factors such as increased pressure on researchers to publish and to produce commercialization of their research. Institutions are perceived to typically respond slowly and inadequately to allegations of research misconduct. More could be done to try to prevent such mis-conduct, such as: (i) educating researchers about research ethics, (ii) assisting and protecting whistleblowers and (iii) instituting processes to adequately and promptly investigate and deal with allegations. In addition, a debate needs to take place as to whether research misconduct allegations should be dealt with at the institutional level or at a national level and whether medical boards should be routinely involved in the more serious breaches of ethical standards by medical practitioners engaged in research. (Intern Med J 2003; 33: 186-191)
机译:摘要医学研究中许多类型的不当行为的例子不断报道。真正的发病率是未知的,因为有充分的证据报告不足,并且建议增加检测。研究参与者的风险可能还会增加,其影响因素包括研究人员发表和进行研究商业化的压力越来越大。人们通常认为机构对研究不当行为的指控反应缓慢且不充分。可以采取更多的措施来防止这种不当行为,例如:(i)向研究人员介绍研究道德规范,(ii)协助和保护举报人,以及(iii)建立适当,迅速地调查和处理指控的程序。此外,还应就是否应当在机构一级或在国家一级处理研究不当行为指控以及医学委员会是否应常规参与从事研究的从业人员更严重地违反道德标准的问题进行辩论。 。 (实习生J 2003; 33:186-191)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号